| |
| |
|
| Insider
Information: |
Scangos George A |
| Relationship: |
Director |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
937,662 |
|
|
Indirect Shares
|
3,762,360 |
|
|
| Direct
Value |
$29,778,144 |
|
|
|
Indirect Value
|
$4,974,217 |
|
|
| Total
Shares |
4,700,022 |
|
|
| Total
Value |
$34,752,361 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Exelixis Inc |
EXEL |
Director |
2020-05-18 |
714,717 |
2020-05-18 |
23,595 |
Premium* |
|
|
Anadys Pharmaceuticals Inc |
ANDS |
Director |
2008-08-26 |
33,188 |
2004-03-31 |
0 |
Premium* |
|
|
Biogen Idec Inc |
BIIB |
Chief Executive Office... |
2016-07-21 |
54,779 |
2016-07-21 |
10,756 |
Premium* |
|
|
Agilent Technologies Inc |
A |
Director |
2024-03-15 |
21,989 |
2024-03-15 |
14,450 |
Premium* |
|
|
Vir Biotechnology, Inc. |
VIR |
Director |
2024-02-26 |
112,989 |
2024-02-26 |
3,713,559 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
376 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 9 of 16
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| EXEL |
Exelixis Inc |
President & CEO |
• • – |
2006-06-21 |
4 |
AS |
$9.66 |
$24,554 |
D/D |
(2,500) |
1,436,131 |
|
- |
|
| EXEL |
Exelixis Inc |
President & CEO |
• • – |
2006-06-29 |
4 |
AS |
$9.72 |
$24,757 |
D/D |
(2,500) |
1,433,631 |
|
- |
|
| EXEL |
Exelixis Inc |
President & CEO |
• • – |
2006-07-05 |
4 |
AS |
$9.75 |
$24,592 |
D/D |
(2,500) |
1,431,131 |
|
- |
|
| EXEL |
Exelixis Inc |
officerTitle |
• • – |
2006-01-05 |
4 |
AS |
$9.80 |
$24,752 |
D/D |
(2,500) |
1,509,841 |
|
- |
|
| EXEL |
Exelixis Inc |
President & CEO |
• • – |
2007-02-27 |
4 |
AS |
$9.85 |
$25,224 |
D/D |
(2,500) |
1,346,131 |
0 |
- |
|
| EXEL |
Exelixis Inc |
President & CEO |
• • – |
2006-10-16 |
4 |
AS |
$9.86 |
$25,000 |
D/D |
(2,500) |
1,393,631 |
0 |
- |
|
| EXEL |
Exelixis Inc |
President & CEO |
• • – |
2006-10-24 |
4 |
AS |
$9.87 |
$25,045 |
D/D |
(2,500) |
1,391,131 |
0 |
- |
|
| EXEL |
Exelixis Inc |
President & CEO |
• • – |
2007-02-01 |
4 |
AS |
$9.90 |
$24,936 |
D/D |
(2,500) |
1,356,131 |
0 |
- |
|
| EXEL |
Exelixis Inc |
President & CEO |
• • – |
2006-02-15 |
4 |
AS |
$9.93 |
$25,268 |
D/D |
(2,500) |
1,494,841 |
|
- |
|
| EXEL |
Exelixis Inc |
President & CEO |
• • – |
2007-01-17 |
4 |
AS |
$9.97 |
$25,282 |
D/D |
(2,500) |
1,361,131 |
0 |
- |
|
| EXEL |
Exelixis Inc |
President & CEO |
• • – |
2007-07-26 |
4 |
AS |
$9.97 |
$25,483 |
D/D |
(2,500) |
1,291,915 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
Director |
– • – |
2024-02-22 |
4 |
AS |
$10.05 |
$100,737 |
D/D |
(10,028) |
130,711 |
0 |
- |
|
| EXEL |
Exelixis Inc |
President & CEO |
• • – |
2007-03-22 |
4 |
AS |
$10.06 |
$25,447 |
D/D |
(2,500) |
1,338,631 |
0 |
- |
|
| EXEL |
Exelixis Inc |
President & CEO |
• • – |
2007-04-03 |
4 |
AS |
$10.08 |
$25,453 |
D/D |
(2,500) |
1,336,131 |
0 |
- |
|
| EXEL |
Exelixis Inc |
President & CEO |
• • – |
2006-05-30 |
4 |
AS |
$10.14 |
$25,681 |
D/D |
(2,500) |
1,443,631 |
|
- |
|
| EXEL |
Exelixis Inc |
President & CEO |
• • – |
2006-02-09 |
4 |
AS |
$10.15 |
$25,951 |
D/D |
(2,500) |
1,497,341 |
0 |
- |
|
| EXEL |
Exelixis Inc |
President & CEO |
• • – |
2006-06-08 |
4 |
AS |
$10.19 |
$26,335 |
D/D |
(2,500) |
1,441,131 |
|
- |
|
| VIR |
Vir Biotechnology, Inc. |
Director |
– • – |
2024-02-20 |
4 |
AS |
$10.22 |
$172,385 |
D/D |
(16,872) |
140,739 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
Director |
– • – |
2024-02-16 |
4 |
AS |
$10.24 |
$111,386 |
D/D |
(10,878) |
157,611 |
0 |
- |
|
| EXEL |
Exelixis Inc |
President & CEO |
• • – |
2006-02-24 |
4 |
AS |
$10.29 |
$26,138 |
D/D |
(2,500) |
1,492,341 |
|
- |
|
| EXEL |
Exelixis Inc |
President & CEO |
• • – |
2007-02-08 |
4 |
AS |
$10.30 |
$26,056 |
D/D |
(2,500) |
1,353,631 |
0 |
- |
|
| EXEL |
Exelixis Inc |
President & CEO |
• • – |
2006-04-11 |
4 |
AS |
$10.34 |
$27,113 |
D/D |
(2,500) |
1,461,131 |
|
- |
|
| EXEL |
Exelixis Inc |
President & CEO |
• • – |
2006-04-17 |
4 |
AS |
$10.41 |
$26,720 |
D/D |
(2,500) |
1,458,631 |
|
- |
|
| EXEL |
Exelixis Inc |
President & CEO |
• • – |
2006-04-27 |
4 |
AS |
$10.50 |
$27,037 |
D/D |
(2,500) |
1,456,131 |
|
- |
|
| EXEL |
Exelixis Inc |
President & CEO |
• • – |
2007-06-08 |
4 |
AS |
$10.62 |
$26,915 |
D/D |
(2,500) |
1,309,415 |
0 |
- |
|
376 Records found
|
|
Page 9 of 16 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
